Administering umbilical cord blood-derived mesenchymal stem cells to treat nerve injury
US9439931B2 · kind B2 · utility
0Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2013 |
| Grant date | Sep 13, 2016 |
| Priority date | — |
| Expiry date | Apr 4, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2502/1358
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A use of a composition comprising umbilical cord blood-derived mesenchymal stem cells for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells is provided, the composition being effective for the treatment of nerve injury diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.